Tatva Chintan: Can it reach 2021 valuations?
This is a company that was once the most popular IPO in 2021 and at the peak of the speciality chemicals cycle. The IPO was oversubscribed over 180x. Yes. 180x The scrip got listed at 21x Mcap/Sales, 15x PB and 90x PE. But now, we believe that the worst is behind us. How? Let’s start …
